Madiha Derouazi

Technik-/Wissenschafts-/F&E-Leiter bei AC IMMUNE SA

Vermögen: 7 271 $ am 30.04.2024

51 Jahre

Health Technology

Consumer Services

Aktive Positionen von Madiha Derouazi

Unternehmen	Position	Beginn	Ende
AC IMMUNE SA	Technik-/Wissenschafts-/F&E-Leiter	01.01.2024	-
Amal Therapeutics SA Amal Therapeutics SA BiotechnologyHealth Technology Amal Therapeutics SA engages in the development of peptide-based therapeutic cancer vaccines. It offers KISMA, a novel peptide/protein-based immunization technology platform, which is self-adjuvanting and enables the assembly within one chimeric fusion protein of elements essential to generate potent immunity. The company was founded by Madiha Derouazi on September 3, 2012 and is headquartered in Geneva, Switzerland.	Direktor/Vorstandsmitglied	03.09.2012	-
	Vorstandsvorsitzender	03.09.2012	-
	Gründer	03.09.2012	-

Unternehmen	Position	Beginn	Ende

Technical University of Berlin	Graduate Degree
Swiss Federal Institute of Technology	Doctorate Degree

International

Schweiz	4
Deutschland	2

Operativ

Sektoral

Health Technology	3
Consumer Services	3

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
AC IMMUNE SA	Health Technology

Private Unternehmen	1
Amal Therapeutics SA Amal Therapeutics SA BiotechnologyHealth Technology Amal Therapeutics SA engages in the development of peptide-based therapeutic cancer vaccines. It offers KISMA, a novel peptide/protein-based immunization technology platform, which is self-adjuvanting and enables the assembly within one chimeric fusion protein of elements essential to generate potent immunity. The company was founded by Madiha Derouazi on September 3, 2012 and is headquartered in Geneva, Switzerland.	Health Technology

Private Unternehmen

Health Technology